Utilization, effectiveness, and safety of tranexamic acid use in hip fracture surgery: A population-based study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32025142.
- Also identified by DOI 10.1016/j.jor.2020.01.040 and PMC identifier 6997115.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess the effect of tranexamic acid (TXA) use in hip fracture surgery. A retrospective cohort study was performed using the Premier Healthcare database. A propensity score matching approach was applied to assess associations between TXA use and blood transfusion, perioperative complications, length of stay (LOS), and hospitalization cost. In 153,169 patients, TXA use was associated with a 17% decrease in odds of blood transfusion, no increase in the risk of perioperative complications, 16% shorter LOS, and minimal effects on hospitalization cost. Our results are in support of a wider use of TXA in hip fracture surgery. Level III.
Anatomy
- hip